arXiv:2606. 01566v1 Announce Type: new Abstract: Small-to-medium scientific datasets place machine learning pipelines under two compounding pressures.
By Amanda S Barnard
arXiv:2605. 25050v2 Announce Type: replace-cross Abstract: Integrating multimodal datasets in clinical oncology is frequently hindered by high dimensionality and blockwise missingness, where entire data sources are unavailable for specific patient subsets.
By Mohamed Boussena, Florence Monville, Jacques Fieschi-Meric, Frederic Vely, Pierre Milpied, Julien Mazieres, Maurice Perol, Eric Vivier, Laurent Greillier, Fabrice Barlesi, Sebastien Benzekry
arXiv:2607. 17345v1 Announce Type: new Abstract: Background: Untargeted LC-MS metabolomics requires a long chain of preprocessing decisions, each with several equally defensible options.
By Mohammed Saeed Al-Huraibi, Ihsan Yozgat, Ahmet Kaplan
arXiv:2607. 01001v1 Announce Type: cross Abstract: Radiomics is the established approach for CT-based lung cancer phenotyping, yet comparisons with foundation models rarely isolate contributions of feature extractor, classification head, and segmentation choice, or test cross-cohort robustness.
By Nils Neukirch, Martin Maurer, Nils Strodthoff
arXiv:2603. 02221v2 Announce Type: replace-cross Abstract: In clinical tabular prediction, classical machine learning models with feature engineering often outperform neural methods.
By Zizheng Zhang, Yiming Li, Justin Xu, Jinyu Wang, Rui Wang, Lei Song, Jiang Bian, David W Eyre, Jingjing Fu
arXiv:2608. 14866v1 Announce Type: cross Abstract: Objective: Small-sample molecular classification requires feature selectors that identify predictive, stable, and nonredundant subsets for binary and multiclass outcomes.
By Zardad Khan, Amjad Ali, Naz Gul, Sheema Gul, Saeed Aldahmani
arXiv:2606. 11144v1 Announce Type: new Abstract: Resistance to first-line osimertinib in EGFR-mutant non-small-cell lung cancer (NSCLC) is the canonical example of predictable clonal evolution under therapeutic pressure, yet no public benchmark exists for training or evaluating computational models on the corresponding longitudinal patient trajectories.
By Abhijoy Sarkar, Aarchi Singh Thakur
arXiv:2607. 16250v1 Announce Type: cross Abstract: Estrogen Receptor (ER) status is a critical biomarker in breast cancer diagnosis, prognosis, and treatment selection.
By Priyanka Paudel, Madan Baduwal
arXiv:2607. 09165v1 Announce Type: cross Abstract: Achieving early and timely diagnosis and treatment for disease is a major challenge.
By Qingchu Jin, Felistas Mazhude, Jamie B. Rabb, Robert S. Kramer, Douglas B. Sawyer, Raimond L. Winslow
arXiv:2607. 07725v1 Announce Type: cross Abstract: Genomic prediction models often fail to transfer across institutions because sequencing panels differ across sites, creating structural feature missingness at deployment.
By Muhammet Sami Yavuz, Ayhan Can Erdur, Sabri Mustafa Kahya, Benedikt Wiestler, Jana Lipkova
arXiv:2608. 07609v1 Announce Type: cross Abstract: High-throughput screening (HTS) assays are central to early-stage drug discovery but are often limited by extreme data sparsity, as primary screens typically use only a single replicate per test substance.
By Xiaohua Douglas Zhang
arXiv:2606. 04453v1 Announce Type: cross Abstract: Radiomics enables extraction of quantitative imaging biomarkers from medical images and has become an important tool for computer-aided cancer diagnosis.
By Hina Shakir, Mohammad Mohatram, Javeed Hussain, Syed Rizwan Ali, Muhammad Irfan Memon